NIOX AB is a corporate office located in Uppsala that specializes in point-of-care fractional exhaled nitric oxide (FeNO) measurement and monitoring. The company focuses on enhancing asthma diagnosis and management through its innovative product line, including the 'FeNO by NIOX®' range. This technology enables healthcare professionals to visualize airway inflammation, which is crucial for developing effective asthma management strategies.
The organization is committed to improving patient care and outcomes by providing accurate and reliable results. NIOX AB maintains a global network that supports healthcare professionals in their efforts to manage respiratory health. Through collaborations with healthcare providers worldwide, the company aims to advance solutions that address the complexities of asthma and other respiratory conditions.